The defects identified in the mechanical activity of the hearts from type 1 diabetic animals include alteration of Ca 2؉ signaling via changes in critical processes that regulate intracellular Ca 2؉ concentration. These defects result partially from a dysfunction of cardiac ryanodine receptor calcium release channel (RyR2). The present study was designed to determine whether the properties of the Ca 2؉ sparks might provide insight into the role of RyR2 in the altered Ca 2؉ signaling in cardiomyocytes from diabetic animals when they were analyzed together with Ca 2؉ transients. Basal Ca 2؉ level as well as Ca 2؉ -spark frequency of cardiomyoctes isolated from 5-week streptozotocin (STZ)-induced diabetic rats significantly increased with respect to aged-matched control rats. Ca 2؉ transients exhibited significantly reduced amplitude and prolonged time courses as well as depressed Ca 2؉ loading of sarcoplasmic reticulum in diabetic rats. Spatio-temporal properties of the Ca 2؉ sparks in cardiomyocytes isolated from diabetic rats were also significantly altered to being almost parallel to the changes of Ca 2؉ transients. In addition, RyR2 from diabetic rat hearts were hyperphosphorylated and protein levels of both RyR2 and FKBP12.6 depleted. These data show that STZ-induced diabetic rat hearts exhibit altered local Ca 2؉ signaling with increased basal Ca 2؉ level.
D
iabetic cardiomyopathy as a distinct entity was first recognized by Rubler et al. (1) in diabetic patients with congestive heart failure who had no evidence of coronary atherosclerosis. Both electrical and mechanical properties of the myocardium from diabetes are significantly impaired (2) (3) (4) (5) . Ventricular myocardium from diabetic rats exhibits a reversible decrease in the speed of contraction, prolongation of contraction, and a delay in relaxation.
Contraction is initiated when a small amount of Ca 2ϩ entering into the cell following membrane depolarization triggers a larger release of Ca 2ϩ from the sarcoplasmic reticulum (SR). Spontaneous local Ca 2ϩ transients, or Ca 2ϩ sparks, are short-lived Ca 2ϩ release events that are believed to demonstrate the main events of excitationcontraction in cardiomyocytes (6, 7) . The global increase in the amount of free Ca 2ϩ in cardiomyocyte during depolarization consists of the summation of these unitary Ca 2ϩ release events in cardiomyocytes (8) and skeletal muscle (9) . On the other hand, it is generally agreed that any alteration of Ca 2ϩ signaling could be a main source of cardiomyopathy (10) . Since the Ca 2ϩ flux underlying the Ca 2ϩ sparks reports the summation of ryanodine-sensitive Ca 2ϩ release channel (RyR2) behavior in the spark cluster, evaluation of the properties of the Ca 2ϩ sparks may provide insight into the role of RyR2 in the altered Ca 2ϩ signaling in cardiomyocytes from diabetic animals (3, 4, 11, 12) .
Depression in contraction and relaxation of myocytes isolated from streptozotocin (STZ)-induced diabetic rats was found in parallel with reduced rate of rise and decline of intracellular Ca 2ϩ transient elicited by electrical stimulation (5) . These effects were mostly attributed to anomalous SR pump activity (11) and SR Ca 2ϩ storage (3) and in part to reduced Na ϩ /Ca 2ϩ exchange (13) and RyR2 protein expression. However, a change in RyR2 expression was not observed in this same model (14) nor in the diabetic db/db mouse (15) . It rather was proposed that the RyR2 properties are altered. Dysfunction of RyR2 induced by diabetes could be, in part, due to formation of disulfide bonds between adjacent sulfhydryl groups (16) , while chronic diabetes increases advanced glycation end products (16, 17) .
The goal of the present study was to specifically examine the behavior of the RyR2 receptors in diabetic rats. We reported here for the first time that local Ca 2ϩ release events (Ca 2ϩ sparks) in ventricular cardiomyocytes from STZ-induced diabetic rats are slower and have higher frequency with respect to the controls, consistent with alterations in Ca 2ϩ handling and cardiac dysfunction. The changes in RyR2 opening kinetics could be related to hyperphosphorylation of RyR2 and FKBP12.6 release.
RESEARCH DESIGN AND METHODS
Diabetes was induced by a single intraperitoneal injection of STZ (50 mg/kg body wt and dissolved in 0.1 mol/l citrate buffer, pH 4.5) in adult male Wistar rats (200 -250 g body wt). Control rats received citrate buffer alone. One week after injection of STZ, blood glucose levels were measured, and rats with blood glucose at least three times higher than the preinjection levels were used. All rats had free access to standard rat diet and water. All animals were used 5 weeks after STZ or citrate buffer injections. All experiments were performed in accordance with Ankara University School of Medicine ethics guidelines for the care and use of laboratory animals.
Cell isolation. Hearts were removed rapidly and weighted after rats had been anesthetized with sodium pentobarbital (30 mg/kg body wt). Hearts were cannulated on a Langendorff apparatus and perfused retrogradely through the coronary arteries with a Ca 2ϩ -free solution (in mmol/l): 145 NaCl, 5 KCl, 1.2 MgSO 4 , 1.4 Na 2 HPO 4 , 0.4 NaH 2 PO 4 , 5 HEPES, and 10 glucose (pH 7.4), bubbled with O 2 at 37°C. Hearts were perfused for 3-5 min to clean out the remaining blood; this was followed by perfusion with the same solution containing 1 mg/ml collagenase (Collagenase A, Boehringer) for 30 -35 min. Ventricles were then removed and minced into small pieces and gently massaged through a nylon mesh, and dissociated cardiomyocytes were washed with the collagenase-free solution. The percentage of viable cells was Ͼ70% in either group. Subsequently, Ca 2ϩ was increased in a graded manner to a concentration of 1 mmol/l. Cells were kept in this solution at 37°C until used in the experiments. The percentage of Ca 2ϩ -tolerant cells was ϳ60%. Global cytosolic Ca 2؉ measurement. Intracellular Ca 2ϩ transients were measured by fura-2 fluorescence at room temperature (21 Ϯ 2°C). The cells were incubated at 37°C for 50 min with 4 mol/l fura-2 AM for loading and then washed with fresh buffer. Fluorescence was recorded using a PTI Ratiomaster microspectrophotometer and FELIX software (Photon Technology International). Cells were excited at 340/380 nm and emission measured at 510 nm. ) were recorded at room temperature (22 Ϯ 2°C) using the whole-cell configuration of the patch clamp technique in the presence of cesium to inhibit K ϩ currents and using voltage ramp by using a patch-clamp amplifier (Model RF-300; Biologic, Claix, France) and filtered at 3 kHz. Current traces were digitized at 5 kHz using Digidata 1200 and pClamp 8 software (Axon Instruments, Foster City, CA). The electrode resistance was 1.2-1.5 mol/l⍀.
Pipette solution for I CaL contained (in mmol/l): 120 CsCl, 6.8 MgC1 2 , 5.0 phosphocreatine-Na 2 , 5.0 ATP-Na 2 , 11 EGTA, and 20 HEPES (pH 7.2). The bathing solution for Ca 2ϩ currents contained (in mmol/l): 117 NaCl, 1.7 MgCl 2 , 5.4 CsCl 2 , 10 HEPES, 1.8 CaCl 2 , and 11 glucose (pH adjusted to 7.4 with NaOH). I CaL was recorded during 250-ms depolarizing pulses to potentials between Ϫ50 and ϩ60 mV (with 10-mV steps) applied at a frequency of 0.2 Hz after a 500-ms ramp to Ϫ45 mV from a holding potential of Ϫ80 mV. Current amplitude was estimated as the difference between peak inward current and the current level at the end of the 250-ms pulse. Ca 2؉ spark measurement. Cardiomyocytes were placed into the recording chamber, which was set onto the stage of an inverted microscope equipped with a laser scanning confocal microscope (200 mol/l; LSM-Pascal, Zeiss, Germany). In the experiments, 40ϫ (NA 1.3) oil immersion objectives were used for imaging cardiomyocytes located over the cover glass base of the recording chamber. A 488-nm laser line from an argon laser (25 mW) was used to excite the Ca 2ϩ -sensitive dye, Fluo-3, and emitted fluorescence collected at 505 nm. Changes in [Ca 2ϩ ] i were recorded in line-scan mode (spatial [x] vs. temporal [t], 1.9 ms/line). To prevent photo-bleaching and cell damage, the laser line was kept at 4 -6% of maximal intensity and the confocal pinhole set to 1-1.5 airy units to achieve the best resolution and emission intensity.
Image analysis was performed using LSM Image Examiner. The F value for fluorescence intensity of image was calculated by averaging pixels other than potential spark areas. Then ⌬F/F image was created by using this F value. Ca 2ϩ sparks were manually detected and converted to temporal lines by averaging fluorescence intensity of 2-3 pixels aligning the peak of fluorescence intensity over time. The signals were filtered using a Butterworth digital filter. The temporal profiles were then fitted to gamma function to analyze time to peak, peak amplitude of fluorescence intensity, and decrease time to half-maximum. Western blot analysis. Hearts were homogenized with a motor-driven Teflon-to-glass homogenizer in cold Tris-HCl buffer containing (in mmol/l): 50 Tris-HCl (pH 7.4), 200 NaCl, 20 NaF, 1.0 Na 3 VO 4 , 1 dithiothreitol, and protease inhibitors (complete tablet from Roche) and centrifuged at 1000g for 30 min at 4°C. Supernatant was centrifuged at 30,000g for 30 min, then at 100,000g for 1 h at 4°C. Pellet was suspended with the homogenization buffer and protein amount measured (18) . The samples (100 g protein) were subjected to 5% SDS-PAGE for RyR2 assay and 10% SDS-PAGE for both FKBP12.6 and actin assays and then transferred electrophoretically to nitrocellulose membrane. Immunoblotting was performed using antibodies against RyR2, RyR2-P (kind gift of Drs. A. Marks and X. Wehrens; dilutions 1/5,000 and 1/3,000, respectively), FKBP12.6, and actin (Santa Cruz), and then enhanced chemoluminescence. Briefly, nitrocellulose membranes were incubated 1 h at 4°C in PBS (20 mmol/l NaH 2 PO 4 -Na 2 HPO 4 , pH 7.6, containing 154 mmol/l NaCl, 3% BSA, and 8% nonfatty dry milk). Blots were washed several times with PBS containing 0.1% Tween and then incubated with antiserum at room temperature for 1-2 h by shaking. Blots were then washed several times with PBS, incubated with horseradish peroxidase-labeled anti-rabbit IgG (Santa Cruz Biotech, Santa Cruz, CA) (dilution 1/10,000) for 1 h at room temperature. Blots were washed several times with PBS and then incubated with ECL Western blotting reagent (Amersham, Vienna, Austria) for 1 min and exposed to X-ray film for 45-90 s.
RESULTS

General characteristics of STZ-induced diabetic rats.
Diabetic animals had significantly high glucose levels (458 Ϯ 8 mg/dl) compared with control animals (101 Ϯ 1 mg/dl). They stopped gaining weight (213.6 Ϯ 9.2 vs. 197.8 Ϯ 7.9 g) following STZ injection, while control animals continued to gain weight (215.0 Ϯ 4.9 vs. 249.2 Ϯ 6.8 g) at the end of the 5-week experimental period. The heart weight-to-body weight ratio was 4.08 Ϯ 0.58 vs. 4.04 Ϯ 0.38 mg/g in the diabetic versus control groups. To avoid the possible insensitive heart-weight measurement, we also measured the capacitance of the isolated cardiomyocytes and compared the values between the groups. The mean cell capacitances of the control and diabetic rats were similar as previously reported (189.9 Ϯ 12.2 and 180.6 Ϯ 13.6 pF, respectively) (19) . Global Ca 2؉ homeostasis in diabetic rat heart. Figure  1A shows original recordings of Ca 2ϩ transients elicited in control and diabetic rat cardiomyocytes. The averaged peak amplitude of ⌬F 340/380 was significantly smaller in diabetic than in control cells (0.23 Ϯ 0.01 and 0.35 Ϯ 0.02 AU, respectively) (Fig. 1B) . The time to peak amplitude of Ca 2ϩ transients of diabetic cells (0.26 Ϯ 0.01 s) was significantly larger than the control ones (0.18 Ϯ 0.01 s), and the half-time for recovery, half-decay time was significantly prolonged with respect to the controls (0.64 Ϯ 0.02 vs. 0.50 Ϯ 0.02 s).
The averaged diastolic values of ⌬F 340/380 were 0.49 Ϯ 0.01 and 0.41 Ϯ 0.01AU in diabetic and control groups, respectively (P Ͻ 0.001). This is indicative that the basal [Ca 2ϩ ] i level is larger in the diabetic groups (Fig. 1C) sparks activity observed in the diabetic group with respect to the control group in the present study, I CaL was examined with whole-cell patch-clamp technique. The densities of I CaL of both groups were similar at all voltages from Ϫ50 to ϩ60 mV. The average peak current densities measured at 0 mV are given in Fig. 1D . Besides the amplitudes (10.9 Ϯ 0.7 and 10.2 Ϯ 0.5 pA/pF in control vs. diabetes, respectively), the fast and slow activation time constants of I CaL (8.1 Ϯ 1.2, 52.9 Ϯ 7.1, and 7.6 Ϯ 1.9 ms; 54.9 Ϯ 5.8 ms in control vs. diabetes) obtained by fitting a twoexponential curve (17) were found to be similar (Fig. 1D,  inset) . Fig. 2A . Representative temporal and averaged spatial profiles of Ca 2ϩ sparks recorded in cells from a control and a diabetic rat are given in Fig. 2B .
The spatial time courses were extracted as the mean of all recorded spatial or temporal pixels centered at the peak of the ⌬F/F of the Ca 2ϩ spark. These transients were then fitted by a gamma distribution function to obtain objective kinetic and spatial measures of the events (19) .
Quantitative data for Ca 2ϩ spark characteristics are summarized in Fig. 2C . Peak amplitude determined as 
Ca 2؉ SPARKS IN DIABETIC CARDIOMYOCYTES
⌬F/F at the peak of Ca 2ϩ spark, frequency of Ca 2ϩ sparks width at half-maximal amplitude, time to peak, and time to half decrease were calculated from individual gamma distribution function fits. The mean peak amplitude of the diabetic group (⌬F/F) was not changed (0.51 Ϯ 0.02 and 0.56 Ϯ 0.02 AU in diabetic and control, respectively), but time to peak was significantly slower (12.88 Ϯ 0.50 and 9.08 Ϯ 0.30 ms in diabetic and control groups, respectively) as well as time to half decrease, which prolonged from 20.78 Ϯ 0.87 to 32.90 Ϯ 1.29 ms with respect to the control group (P Ͻ 0.0001). The spatial spread (frequency of Ca 2ϩ sparks width at halfmaximal amplitude) was not significantly different in the diabetic group with respect to the control group (2.45 Ϯ 0.85 vs. 2.05 Ϯ 0.92 m) (Fig. 2D, left) . Spontaneous Ca 2ϩ sparks frequency was higher (P Ͻ 0.0001) in diabetic cardiomyocytes (0.051 Ϯ 0.007 s (Fig. 2D, right) . SR Ca 2؉ content of cardiomyocytes. Caffeine application caused a sudden and transient increase in intracellular Ca 2ϩ of cardiomyocytes due to Ca 2ϩ release from SR. The size of the caffeine-induced Ca 2ϩ transient has been used to assess the SR Ca 2ϩ load of control and diabetic cardiomyocytes. To assure stable SR Ca load, cells were first stimulated and caffeine (10 mmol/l) rapidly applied 30 s after cessation of electrical stimulation. The caffeineinduced Ca 2ϩ transient recorded in cardiomyocytes from diabetic rats was smaller than the corresponding control one (Fig. 3A) . The averaged caffeine responses (⌬F/F) were 0.42 Ϯ 0.02 vs. 0.36 Ϯ 0.02 AU in the control versus diabetic cells, and the difference between these two groups is statistically significant (Fig. 3B) . Effects of insulin on Ca 2؉ sparks. To clarify whether the altered parameters of Ca 2ϩ sparks arise due to STZinduced diabetes (type 1, insulin-dependent diabetes) or a result of the direct toxic effect of STZ on cardiomyocytes, cells from diabetic rats were incubated in the presence or not of insulin (100 nmol/l) for 4 -5 h at 37°C. Then, we recorded Ca 2ϩ sparks and calculated the time to peak and the time to half decrease of the sparks. The mean peak amplitudes of the sparks (⌬F/F) from these two groups of cells were not affected by insulin incubation, but the time to peak of the insulin incubated group of cells (58 sparks in five cells from two rats) was significantly recovered (10.06 Ϯ 0.30 vs. 13.03 Ϯ 0.52 ms) compared with untreated cells (45 sparks in four cells from two rats). Also, time to half increase was recovered from 30.04 Ϯ 1.81 to 25.06 Ϯ 1.19 ms (P Ͻ 0.001). If we compare these parameters with those from normal controls (time to peak 9.08 Ϯ 0.30 ms, time to half decrease 20.78 Ϯ 0.87 ms), we can see significant recoveries with insulin incubation of the cardiomyocytes from STZinduced diabetic rats (Fig. 3C ).
Biochemical analysis of RyR2 in diabetes.
The mechanisms underlying the dysfunction of RyR2 in diabetes remain undefined. We hypothesized that the alterations in Ca 2ϩ release behavior seen at the global and local spark level in STZ-induced diabetic rat cardiomyocytes could be due to a defect in RyR2 function following its phosphorylation and release of FKBP12.6, an accessory protein of RyR2 macromolecular complex, as documented in heart failure (20) . The phosphorylation level of RyR2 in diabetic and control rat heart tissue was evaluated using specific antibodies directed against RyR2 and phosphorylated RyR2 (Fig. 4A) . Total RyR2 in the diabetic groups was ϳ44% less than in the control group as estimated from the Western-blot bands (Fig. 4B) . There is strong evidence of phosphorylation of RyR2 in diabetic rat heart but no appearance of it in the control rat hearts. The amount of FKBP12.6 was decreased by 41% in the diabetic rat heart compared with the control rat heart (Fig. 4B) . There was no significant difference in the protein levels of actin in diabetic and control groups (Fig. 4B) .
DISCUSSION
This study on STZ-induced type 1 diabetes in rats reports significant alterations in Ca 2ϩ homeostasis that can ac- count for the well-known contractile dysfunction in such pathological conditions. At first we confirmed the defective intracellular Ca 2ϩ signaling with both lower amplitude and slower kinetics of Ca 2ϩ transients as well as the decreased SR Ca 2ϩ load (5). Furthermore, we clearly established that these defects could be attributed to anomalous RyR2 behavior, as revealed by the spatio-temporal properties of Ca 2ϩ sparks that especially exhibited slower kinetics. The reduced amount of RyR2 and FKBP12.6 levels and the protein kinase A-dependent phosphorylation of RyR2 could be responsible for most of these observations. A lower SR Ca 2ϩ load reinforced these defects in Ca 2ϩ release channel properties. The diabetic cardiomyopathy, starting with asymptomatic left ventricular diastolic dysfunction, progresses to compromised systolic function that leads to increased incidence in morbidity and mortality. Coincident with the alteration of cardiac function are a variety of metabolic and biochemical abnormalities that include change in the predominance of myosin isoenzymes (21) , an activity of the SR Ca 2ϩ -ATPase (3, 5, 11, 22, 23) . In addition, diabetes has been associated with a reversible increase in the duration of the action potential attributable to a reduced transient outward K ϩ current (I K1 ), while the L-type Ca 2ϩ current (I CaL ) was unaffected (5,24 -26) . Thus, diabetes exhibits some similarities with heart failure in which it has been reported that I K1 is reduced as a consequence of elevated diastolic Ca 2ϩ following altered RyR2 properties (27) .
Despite the fact that I CaL is not modified by diabetes, the cardiomycytes from diabetic rats demonstrate significant alterations in Ca 2ϩ homeostasis. These include increases in rise time and half-decay time of Ca 2ϩ transient together with decrease in Ca 2ϩ transient amplitude and SR Ca 2ϩ load as well as increase in diastolic Ca 2ϩ . All these changes could be consequent to the alterations in RyR2 behavior that we describe here. The decrease in SR Ca 2ϩ load has been reported in several previous studies (5) and was already suggested by rapid cooling contracture experiments (28) . This is attributable to reduced sarcoplasmic reticulum Ca-ATPase and increased phospholamban expression (29, 30) as well as to the anomalous RyR2 activity. These factors could also be responsible for the larger diastolic Ca 2ϩ level seen here in diabetic cells (31) (32) (33) , although others reported no change (34, 35) or even a decrease (36, 37) . However, this latter work (37) was performed using a low-Ca (0.5 mmol/l)-containing extracellular solution. It needs to be emphasized that the current controversy in resting Ca 2ϩ levels in both tissue and isolated myocytes in diabetic hearts is under consideration and needs to be clarified with additional data.
Our data also show that insulin incubation of the cardiomyocytes from diabetic rats for 4 h significantly restored the altered parameters of Ca 2ϩ sparks and thus provides support for the origin of these alterations. It is well known that STZ can induce cardiac dysfunction depending on insulin deficiency (type 1 diabetes), while insulin treatment of these animals/cells could recover almost all of these parameters (25,28,38 -41) . Besides these published data, it has been shown that altered SR Ca 2ϩ content and RYR2 binding, altered SR protein expression, as well as altered RyR2 mRNA levels and RyR2 protein levels (5, 14, 17) were normalized following insulin treatment of the STZ-induced diabetic animals in vivo and/or in vitro.
It (9) . This similar conclusion could be made in cardiomyocytes. Alternatively, the decay phase of spark fluorescence is characterized by the diffusion of Ca 2ϩ away from the SR and is thought to be independent of SERCA activity. Thus, the spark decay may be influenced by intrinsic Ca 2ϩ buffering processes (42) . The Western blot analysis supports altered activity of RyR2 in diabetes. There are, however, controversies about the RyR2 properties in diabetes. Similar data were published by Guatimosim et al. (12) and Bidasee et al. (14) . They have mentioned the importance of evaluation of the properties of the Ca 2ϩ sparks as insight into the role of RyR2 in the altered Ca 2ϩ signaling in diabetic cardiomyocytes. Their data have also shown that although expression did not change significantly after 6 weeks of diabetes, the ability of RyR2 to bind the specific ligand [ 3 H]ryanodine was significantly lowered (14) . These authors also demonstrated that chronic diabetes (8 weeks) induced a decrease in cardiac contractility in part due to a decrease in expression and an alteration in function of RyR2 (16) .
Another origin of altered parameters of Ca 2ϩ signaling might be the deficiency in SR Ca 2ϩ load. Indeed, a similar application of caffeine released a significantly less amount of Ca 2ϩ from SR, in agreement with previous results by Choi et al. (5) in a similar diabetes model. These studies, therefore, identify important alterations in SR function due to either a decreased level and altered function of RyR2 and/or a depressed level of SERCA.
RyR2 receptors are regulated by a variety of proteins, including FKBP12.6. Due to its importance in the coupled gating of RyR2, its deficit and alteration has been involved in heart failure. However, there are controversies related to its effects on Ca 2ϩ spark parameters (20, 43, 44) . Our data showed that kinetic parameters of Ca 2ϩ sparks are slower in diabetic compared with control rats. These alterations are due to defects in RyR2 receptor behavior. According to the RyR2-coupled gating hypothesis (45), FKBP12.6 allows all RyR2 clusters to open and close simultaneously. Therefore, any type of alteration in this protein, associated here with a decreased amount of RyR2, will cause a depression in both time to peak and time to half decrease of Ca 2ϩ sparks. The question thus arises as to how less RyR2 and FKBP12.6 and phosphorylated RyR2 can cause no significant change in the amplitude of Ca 2ϩ transient together with significant prolongations in both time to peak and time to half decrease. This effect is may be due to leaky SR in diabetes. This hypothesis is consistent with several studies and also supported by our data on both increased basal Ca 2ϩ level and Ca 2ϩ spark frequency in diabetes (5, 15, 46) . A further study on quantitative assessment of RyR2 and FKBP12.6 mRNA levels of hearts from control and diabetic groups is needed to fully clarify their roles in excitation-contraction coupling and its alteration during diabetes.
These alterations in Ca 2ϩ homeostasis might be responsible for heart remodeling that occurs without significant cell growth. Like most others (25, 47) , we observed no change in membrane capacitance, while after longer STZtreatment of younger rats, Choi et al. (5) observed a decrease in membrane capacitance. This was associated with a lack of increase in body weight during the 5 weeks of STZ treatment that indicates a relative cell hypertrophy in diabetic rats. This is in line with the increase in heart weight-to-body weight ratio previously reported (23, 48) .
In summary, we have demonstrated that cardiac contractile dysfunction is closely related to altered Ca 2ϩ signaling as well as altered electrical activity. Therefore, it has been demonstrated for the first time that altered parameters of both Ca 2ϩ transients and Ca 2ϩ sparks are responsible for the altered Ca 2ϩ signaling in diabetes, and these alterations may be in part associated with not only less Ca 2ϩ loading of SR, but also phosphorylation of RyR2 in diabetes.
